HB3454 - 104th General Assembly (2025-2026)

EPINEPHRINE DELIVERY DEVICE
Last Action

2/26/2026 - Senate: Placed on Calendar Order of First Reading March 3, 2026
Statutes Amended In Order of Appearance

Synopsis As Introduced

Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.
Actions

DateChamberAction
2/07/2025HouseFiled with the Clerk by Rep. Joyce Mason
2/18/2025HouseFirst Reading
2/18/2025HouseReferred to Rules Committee
3/11/2025HouseAssigned to Prescription Drug Affordability & Accessibility Committee
3/19/2025HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
3/20/2025HousePlaced on Calendar 2nd Reading - Short Debate
3/26/2025HouseAdded Co-Sponsor Rep. Jawaharial Williams
3/26/2025HouseAdded Co-Sponsor Rep. Harry Benton
3/26/2025HouseAdded Co-Sponsor Rep. Dagmara Avelar
3/26/2025HouseSecond Reading - Short Debate
3/26/2025HouseHeld on Calendar Order of Second Reading - Short Debate
4/08/2025HouseAdded Co-Sponsor Rep. Camille Y. Lilly
4/11/2025HouseRule 19(a) / Re-referred to Rules Committee
1/21/2026HouseAdded Chief Co-Sponsor Rep. Martha Deuter
2/11/2026HouseApproved for Consideration Rules Committee; 005-000-000
2/13/2026HousePlaced on Calendar 2nd Reading - Short Debate
2/25/2026HousePlaced on Calendar Order of 3rd Reading - Short Debate
2/25/2026HouseThird Reading - Short Debate - Passed 105-000-000
2/26/2026SenateArrive in Senate
2/26/2026SenatePlaced on Calendar Order of First Reading March 3, 2026
3/02/2026HouseAdded Co-Sponsor Rep. Michelle Mussman
3/09/2026HouseAdded Chief Co-Sponsor Rep. Janet Yang Rohr